Michael Le Claire
About Michael Le Claire
Michael Le Claire is a Senior Scientist at Capricor Therapeutics, Inc., focusing on exosomes and extracellular vesicles as potential biomarkers and therapeutic agents. He has a multidisciplinary background in chemistry and gender studies, and has contributed to various research projects aimed at advancing nanotechnology in biomedical applications.
Work at Capricor Therapeutics
Michael Le Claire currently serves as a Senior Scientist at Capricor Therapeutics, Inc. in San Diego, California. He has been in this role since 2022. Prior to this position, he worked as a Scientist at the same organization from 2021 to 2022. His work focuses on the potential of exosomes and extracellular vesicles in therapeutic applications and liquid biopsy biomarkers.
Education and Expertise
Michael Le Claire holds a Doctor of Philosophy (Ph.D.) in Chemistry from the University of California, Los Angeles, which he completed from 2016 to 2021. He also earned a Bachelor's Degree in Chemistry from the University of Pittsburgh from 2012 to 2016, where he also obtained a Certificate in Gender, Sexuality, and Women's Studies. His educational background supports a multidisciplinary approach to scientific research.
Background
Michael Le Claire's academic journey began at Avon Grove High School, where he studied from 2008 to 2012. He then worked as an Undergraduate Research Assistant at the University of Pittsburgh from 2013 to 2015 and as an Organic Chemistry Laboratory Undergraduate Teaching Assistant from 2014 to 2015. He later served as a Graduate Student Researcher and Graduate Teaching Assistant at the University of California, Los Angeles from 2016 to 2021.
Research Focus and Contributions
Michael Le Claire's research primarily centers on exosomes and extracellular vesicles. He utilizes atomic force microscopy (AFM) and other biophysical techniques to analyze these structures at the nanoscale. His contributions include developing scalable production and purification methods for exosomes, researching exosomes loaded with siRNA for ovarian cancer treatment, and working on exosome-based multivalent vaccines for epidemic viruses.
Professional Experience
In addition to his current role at Capricor Therapeutics, Michael Le Claire has previous experience as a Mickey Leland Energy Fellow at the National Energy Technology Laboratory in 2015. His diverse roles in academia and industry have equipped him with a comprehensive skill set in biophysical characterization and nanotechnology applications in exosome research.